{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:49:39Z","timestamp":1789778979536,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","endocrinologydiabetes.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Endocrinology and Diabetes"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.aed.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:17:54Z","timestamp":1772093874000},"page":"473-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond Monotherapy: Targeting the Triad of Insulin Resistance, Hyperandrogenism and Obesity in Polycystic Ovary Syndrome"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2552-5807","authenticated-orcid":false,"given":"Amal","family":"Shaharyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.aed.2026.02.008_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"Ganie","year":"2019","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.aed.2026.02.008_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09513590802217027","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome","volume":"24","author":"Wu","year":"2008","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"10.1016\/j.aed.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"issue":"8","key":"10.1016\/j.aed.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede","year":"2013","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41390-019-0615-1","article-title":"Curtailing pcos","volume":"87","author":"Witchel","year":"2020","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1038\/s41598-020-64776-w","article-title":"Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: a systematic review and meta-analysis","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/ijerph18010233","article-title":"Development and effects of college-based lifestyle modification program for menstrual health of young adult women with irregular menses: a randomized controlled trial","volume":"18","author":"Park","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.aed.2026.02.008_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsampl.2023.100024","article-title":"Comparison of selected exercise training modalities in the management of PCOS: a systematic review and meta-analysis to inform evidence-based guidelines","volume":"2","author":"Colombo","year":"2023","journal-title":"JSAMS Plus"},{"issue":"10","key":"10.1016\/j.aed.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/nu11102278","article-title":"Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS)","volume":"11","author":"Barrea","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12902-022-01208-y","article-title":"Lifestyle management in polycystic ovary syndrome\u2013beyond diet and physical activity","volume":"23","author":"Cowan","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.aed.2026.02.008_bib14","series-title":"Oral contraceptive pills","author":"Cooper","year":"2025"},{"issue":"5","key":"10.1016\/j.aed.2026.02.008_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/humupd\/dmt028","article-title":"Venous thromboembolism in women: a specific reproductive health risk","volume":"19","author":"Eichinger","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.aed.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","article-title":"Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins","volume":"73","author":"Amiri","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/j.aed.2026.02.008_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11154-011-9182-4","article-title":"Metabolic effects of contraceptive steroids","volume":"12","author":"Sitruk-Ware","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"10.1016\/j.aed.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.122.20018","article-title":"Oral contraceptive pills and hypertension: a review of current evidence and recommendations","volume":"80","author":"Cameron","year":"2023","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.aed.2026.02.008_bib19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12902-015-0012-7","article-title":"Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period","volume":"15","author":"Biason","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"10.1016\/j.aed.2026.02.008_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls","volume":"35","author":"Cromer","year":"2004","journal-title":"J Adolesc Health"},{"issue":"6","key":"10.1016\/j.aed.2026.02.008_bib23","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.fertnstert.2014.02.039","article-title":"Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients","volume":"101","author":"Mes-Krowinkel","year":"2014","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.aed.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2017-02052","article-title":"Treatment options for hirsutism: a systematic review and network meta-analysis","volume":"103","author":"Barrionuevo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-51-3-429","article-title":"A novel use of spironolactone: treatment of hirsutism","volume":"51","author":"Shapiro","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jcem-66-1-208","article-title":"Side-effects of spironolactone therapy in the hirsute woman","volume":"66","author":"Helfer","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2125.1983.tb01470.x","article-title":"The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol","volume":"15","author":"Fernandez","year":"1983","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib30","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","article-title":"Interaction of spironolactone with oestradiol receptors in cytosol","volume":"84","author":"Levy","year":"1980","journal-title":"J Endocrinol"},{"issue":"19","key":"10.1016\/j.aed.2026.02.008_bib31","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2174\/1381612829666230331093912","article-title":"Do Pleiotropic effects of spironolactone in women with PCOS make it more than an anti-androgen? Evidence from a systematic review and meta-analysis","volume":"29","author":"Bashir","year":"2023","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib32","first-page":"177","article-title":"The 5\u03b1-recluctase system and its inhibitors: recent development and its perspective in treating androgen-dependent skin disorders","volume":"193","author":"Chen","year":"1996","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.aed.2026.02.008_bib33","first-page":"9909","article-title":"Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review","volume":"16","author":"Almudimeegh","year":"2024","journal-title":"Dermatol Rep"},{"issue":"1 suppl","key":"10.1016\/j.aed.2026.02.008_bib34","first-page":"69","article-title":"Flutamide-induced hepatotoxicity: ethical and scientific issues","volume":"21","author":"Giorgetti","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/humupd\/dmx039","article-title":"Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Luque-Ramirez","year":"2018","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","article-title":"Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic\u2013hyperinsulaemic clamp","volume":"28","author":"Stepto","year":"2013","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.aed.2026.02.008_bib37","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.aed.2026.02.008_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.40583","article-title":"Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women","volume":"7","author":"Ganie","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.aed.2026.02.008_bib39","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1210\/jc.2008-0461","article-title":"The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials","volume":"93","author":"Hoeger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib40","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1093\/ejendo\/lvad098","article-title":"The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Melin","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7421","key":"10.1016\/j.aed.2026.02.008_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.aed.2026.02.008_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humrep\/deg056","article-title":"Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome","volume":"18","author":"Ib\u00e1\u00f1ez","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.aed.2026.02.008_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1223768","article-title":"Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.aed.2026.02.008_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102162","article-title":"Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"63","author":"Alesi","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.aed.2026.02.008_bib45","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa032","article-title":"Toward a treatment normalizing ovulation rate in adolescent girls with polycystic ovary syndrome","volume":"4","author":"Ib\u00e1\u00f1ez","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.aed.2026.02.008_bib46","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","article-title":"Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome","volume":"12","author":"Satyaraddi","year":"2019","journal-title":"J Hum Reprod Sci"},{"issue":"2","key":"10.1016\/j.aed.2026.02.008_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EC-16-0113","article-title":"Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential","volume":"6","author":"Nylander","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.aed.2026.02.008_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3389\/fendo.2014.00140","article-title":"The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study","volume":"5","author":"Rasmussen","year":"2014","journal-title":"Front Endocrinol"},{"issue":"18","key":"10.1016\/j.aed.2026.02.008_bib50","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.3390\/jcm12185921","article-title":"Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs","volume":"12","author":"Carmina","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.aed.2026.02.008_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1366940","article-title":"The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: a 2-year observational study","volume":"15","author":"Jensterle","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.aed.2026.02.008_bib52","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.15318.1","article-title":"Recent advances in the understanding and management of polycystic ovary syndrome","volume":"8","author":"Rocha","year":"2019","journal-title":"F1000Research"},{"issue":"26","key":"10.1016\/j.aed.2026.02.008_bib53","doi-asserted-by":"crossref","first-page":"8351","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib54","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.aed.2026.02.008_bib55","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.aed.2026.02.008_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07435800.2014.966385","article-title":"Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome","volume":"40","author":"Jensterle","year":"2015","journal-title":"Endocr Res"},{"issue":"31","key":"10.1016\/j.aed.2026.02.008_bib57","doi-asserted-by":"crossref","first-page":"E875","DOI":"10.1503\/cmaj.191707","article-title":"Obesity in adults: a clinical practice guideline","volume":"192","author":"Wharton","year":"2020","journal-title":"Cmaj"}],"container-title":["AACE Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915726000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050915726000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T09:28:27Z","timestamp":1780046907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050915726000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S3050915726000299"],"URL":"https:\/\/doi.org\/10.1016\/j.aed.2026.02.008","relation":{},"ISSN":["3050-9157"],"issn-type":[{"value":"3050-9157","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Monotherapy: Targeting the Triad of Insulin Resistance, Hyperandrogenism and Obesity in Polycystic Ovary Syndrome","name":"articletitle","label":"Article Title"},{"value":"AACE Endocrinology and Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aed.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Association of Clinical Endocrinology.","name":"copyright","label":"Copyright"}]}}